Medifast Reports Q2 Results
August 5, 2024 Wellness company Medifast (NYSE:MED) fell short of analysts’ expectations. Management said that: “We are acting decisively to transform our business to position
Hims & Hers To Offer Certificates of Analysis for Compounded GLP-1s
August 1, 2024 In August, Certificates of Analysis on the compounded GLP-1 medications available through Hims & Hers will be accessible to customers, in an
Weight Watchers Reports Q2 Results
August 1, 2024 Management reported that: “WeightWatchers has the right strategy to return the business to growth. With a rapidly changing landscape, we are taking
Nearly all patients quit weight loss shots within two years, study finds
July 11, 2024 An article by Endpoints.com cited a study that found that only about 15% of people who began taking GLP-1 drugs such as
Employers and Insurers Push Back on GLP-1 Drugs Coverage
June 13, 2024 Just 33% of employers and health plans cover the drugs for obesity, according to a report published Tuesday by consultant firm Pharmaceutical
Kroger’s Little Clinics Adds GLP-1 Drugs To Its Weight Loss Program
June 11, 2024 Kroger Health’s The Little Clinic LLC is announcing a renewed approach to its weight management program, offering a holistic and personalized approach
Most weight loss drug users quit before seeing benefits
May 22, 2024 A majority of patients taking weight loss drugs discontinue use of their medication before reaching a clinically meaningful health benefit, according to new
Medifast To Launch National Marketing Campaign
May 20, 2024 Medifast today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering